A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix

Clinical trial NCT00264732 · COMPLETED

Trial details

NCT number: NCT00264732
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Uterine Cervical Dysplasia

Start date: 2005-07-01
Primary completion: 2009-05-01
Enrollment: 251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.